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Scope: 8-prenyl quercetin (PQ) is a typical prenylflavonoid distributed in plant foods 28 
and shows higher potential bioactivity than its parent quercetin (Q) although the 29 
mechanisms are not fully understood. This study aims to clarify the anti-inflammatory 30 
effects and molecular mechanisms of PQ in cell and animal models, compared to Q. 31 
Methods and results: RAW264.7 cells were treated with PQ or Q to investigate the 32 
influence on the production of inducible nitric oxide synthase (iNOS), 33 
cyclooxygenase-2 (COX-2) and protein kinases by Western blotting. Nitric oxide (NO) 34 
and prostaglandin E2 (PGE2) were measured by the Griess method and ELISA, 35 
respectively. Cytokines were assayed by the multiplex technology. Mouse paw edema 36 
was induced by lipopolysaccharide (LPS). The results revealed that PQ had stronger 37 
inhibition on the productions of iNOS, COX-2, NO, PGE2, and 12 kinds of cytokines, 38 
than Q. PQ also showed in vivo anti-inflammatory effect by attenuating mouse paw 39 
edema. Molecular data revealed that PQ had no competitive binding to Toll-like 40 
receptor 4 (TLR4) with LPS, but directly targeted SEK1-JNK1/2 and MEK1-ERK1/2. 41 
Conclusion: PQ as a potential inhibitor revealed anti-inflammatory effect in both cell 42 
and animal models at least by targeting SEK1-JNK1/2 and MEK1-ERK1/2. 43 
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1  Introduction 48 
Prenylflavonoids are naturally occurring flavonoids possessing a C5 isoprenoid unit in a 49 
diphenylpropane structure. The roots, leaves and seeds of Moraceace, Leguminosae and 50 
Asteraceae are major sources of prenylflavonoids although more than 1000 51 
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prenylflavonoids have been found in the plants [1, 2]. In recent years, their potential 52 
benefits for human health have been considered because prenylflavonoids are reported 53 
to have antibacterial, antioxidant and estrogenic activities [3]. It is noticed that 54 
prenylation of flavonoids could enhance their biological functions and bioavailability. 55 
For example, prenylation of naringenin and genistein enhanced their estrogenicity [4]. 56 
Prenylated naringenin also enhanced the accumulation of naringenin in muscle tissue, 57 
resulting in the prevention of muscle atrophy in rodent model [5]. Thus, molecular 58 
mechanisms of prenylflavonoids should be taken into account to estimate the biological 59 
functions. 60 
Quercetin (Q) is a representative compound of naturally occurring flavonoid present in 61 
many vegetables and fruits [6]. Extensive data have indicated that Q has many 62 
biological functions [7, 8, 9]. Recent studies have demonstrated that Q has 63 
anti-inflammatory effects in both mouse macrophage cell [10] and rat models [11]. 64 
Moreover, 8-prenyl quercetin (PQ) is found in Desmodium caudatum [12] that is a 65 
traditional herb used for anti-inflammation in Japan [13]. Thus, we challenge to clarify 66 
the effect and molecular mechanisms of anti-inflammation by PQ, compared to its 67 
parent Q. 68 
During inflammatory disease, the primary cells of chronic inflammation are 69 
macrophages that produce excess amounts of mediators such as nitric oxide (NO), 70 
prostaglandin E2 (PGE2), and pro-inflammatory cytokines [14], which play pivotal roles 71 
in consequences of inflammation [15]. Although the cellular signaling pathways 72 
regulating the inflammation are very complicated, mitogen-activated protein kinase 73 
(MAPK) and nuclear factor-kappa B (NF-κB) pathways have been suggested to be key 74 
pathways for the regulations of inflammatory mediator expressions [14]. MAPK can 75 
stimulate the production of inflammatory mediators such as inducible nitric oxide 76 
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synthase (iNOS), cyclooxygenase-2 (COX-2) and cytokines in bacterial 77 
lipopolysaccharide (LPS)-activated macrophages [16, 17, 18]. Moreover, recent several 78 
lines of studies have showed that polyphenolic compounds could directly bind to 79 
MAPK proteins to attenuate the kinase signaling. For example, myricetin [19], 80 
procyanidin B2 [20] could directly bind to MAPK/ERK kinase (MEK) to suppress 81 
MEK phosphorylation and downstream signaling. 82 
Based on the properties of prenylflavonoids and the information of inflammation 83 
processes, we investigated the anti-inflammatory effects and molecular mechanisms of 84 
PQ, compared to Q. First of all, we used mouse macrophage-like cells (RAW264.7), 85 
which can be stimulated with LPS to mimic a status of infection and inflammation, to 86 
screen the influence of PQ on the productions of iNOS, NO, COX-2, PGE2, and 87 
cytokines. Then, we confirmed the in vivo anti-inflammatory effects of PQ using a 88 
mouse paw edema model. Finally, we investigated the modulation of PQ on 89 
LPS-induced inflammatory signaling pathway, and challenged to clarify the molecular 90 
targets of PQ by chemical biology approaches.  91 
 92 
2  Materials and methods 93 
2.1  Materials 94 
PQ (Fig. 1A) was synthesized as described previously [21]. Q (Fig. 1B) was purchased 95 
from Sigma (St. Louis, MO, USA). PQ and Q were dissolved in DMSO (0.2% final 96 
concentration in cultural medium). LPS and fluorescein isothiocyanate (FITC) 97 
conjugated-LPS (Escherichia coli Serotype 055:B5) were from Sigma (St. Louis, MO, 98 
USA). The antibodies against iNOS, COX-2, MEK1, α-tubulin and anti-goat IgG-HRP 99 
were from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA). The other antibodies 100 
were from Cell Signaling Technology (Beverly, MA, USA). CNBr-activated Sepharose 101 
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4B was from GE Healthcare. 102 
 103 
2.2  Cell culture 104 
RAW264.7 cells were purchased from the American Type Culture Collection (Manassas, 105 
VA, USA) and cultured in Dulbecco's modified Eagle's medium containing 10% fetal 106 
bovine serum (FBS), 4 mM L-glutamine, and 2 mM Penicillin-Streptomycin Mixed 107 
Solution. After pre-culture for 24 h, the cells were starved in serum-free medium to 108 
eliminate the influence of FBS. The cells were then treated for 30 min with PQ or Q or 109 
DMSO as control vehicle (0.2% final concentration of DMSO in cultural medium) 110 
before exposure to 40 ng/mL LPS for the indicated times in each experiment. 111 
 112 
2.3  Measurement of nitrite and PGE2 113 
Nitrite was measured to estimate NO production with the Griess method [22]. In brief, 114 
RAW264.7 macrophage cells (1 ×106 cells/dish) were seeded into 6-cm dish. The cells 115 
culture and treatments were described in Section 2.2, and the culture medium from each 116 
dish was collected after LPS treatment for 12 h. The nitrite concentration in the culture 117 
medium was detected by the reaction with the Griess reagent for 10 min at room 118 
temperature, and the absorbance was measured at 550 nm wavelength. 119 
PGE2 in cultural medium was measured with a PGE2 enzyme immunoassay kit 120 
(Cayman Co., St. Louis, MO) according to manufacturer’s manual [23]. In brief, 121 
RAW264.7 cells (1.2 × 105 cells/well) were seeded into each well of 12-well plates. The 122 
cells culture and treatments were described in Section 2.2, and the culture medium from 123 
each well was collected after LPS treatment for 12 h. The level of PGE2 released into 124 
culture medium was determined by measuring absorbance at 405 nm in a microplate 125 
reader. 126 
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 127 
2.4  Cytokine determination by the multiplex technology 128 
The method has been described in our previous report [24]. In brief, RAW264.7 cells 129 
(1.2×105 cells/well) were seeded into each well of 12-well plate. The cells culture and 130 
treatments were described in Section 2.2, and the culture medium from each well was 131 
collected after LPS treatment for 12 h. The levels of cytokines in culture medium was 132 
measured with Bio-Plex Pro Mouse Cytokine 23-Plex Panel kit (Bio-Rad Laboratories) 133 
including IL-1α, IL-1β, IL-2, IL-3, IL-4, IL-5, IL-6, IL-9, IL-10, IL-12(p40), 134 
IL-12(p70), IL-13, IL-17, Eotaxin, G-CSF, GM-CSF, IFN-γ, KC, MCP-1, MIP-1α, 135 
MIP-1β, RANTES and TNF-α. The assay was performed with a Bio-Plex machine 136 
(Bio-Plex 200 System, Bio-Rad) according to the manufacturer’s instructions, and the 137 
data were analyzed with the Bio-Plex manager software (version 5.0). 138 
 139 
2.5  Western blotting 140 
Western blotting was performed as described previously [22]. In brief, RAW264.7 cells 141 
(1 ×106 cells/dish) were seeded into each 6-cm dish. The cell culture and treatments 142 
were described in Section 2.2. The cells were lysed in a lysis buffer, and boiled for 5 143 
min. Approximately 20-60 µg of proteins were run on 10% SDS-PAGE and then 144 
transferred to PVDF membrane (GE Healthcare, UK). The blotted membrane was 145 
incubated with specific primary antibody overnight at 4 °C and further incubated for 1 h 146 
with HRP-conjugated secondary antibody. Bound antibodies were detected by ECL 147 
agent and further quantified by Lumi Vision Imager software (TAITEC Co., Japan). 148 
 149 
2.6  In vivo paw edema model 150 
The animal experiments were conducted in accordance with the guidelines of the 151 
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Animal Care and Use Committee of Kagoshima University (Permission N0. A12005). 152 
Male ICR mice (4 weeks old) from Japan SLC Inc were group-housed under controlled 153 
light (12 h light/day) and temperature (25 °C). All the animals had free access to water 154 
and feed in a home cage. The mice were randomly divided into four groups: control, 155 
LPS, LPS plus PQ or Q. PQ or Q was dissolved in PBS containing 2% DMSO and 156 
administered to the mice in 1 μM/kg for PQ or 2 μM/kg for Q by intraperitoneal (i.p.) 157 
injection for 4 days. LPS were then injected subcutaneously (s.c.) to paw in a dose of 1 158 
mg/kg. Paw thickness was measured using caliper (model 19975, Shinwa Rules Co. 159 
Ltd) before and every hour after LPS treatment until 3 h. After 3 h, mice were sacrificed 160 
and blood serums were collected from heart. The serums without any dilution were used 161 
to detect IL-6 by mouse ELISA Ready-SET-Go kit (eBioscience) according to 162 
manufacturer’s instructions. 163 
 164 
2.7  Flow cytometric assay 165 
The competition assay of PQ and LPS for Toll-like receptor 4 (TLR4) was performed by 166 
flow cytometry using the FITC-conjugated LPS [25]. RAW264.7 cells (5×105 cells/ml 167 
in serum-free medium) were treated with or without PQ (15 μM) or cold-LPS (non 168 
FITC-conjugated LPS) (100 ng/ml) for 30 min before expose to FITC-LPS (10 ng/ml) 169 
for 30 min. After washing, the fluorescence emitted was analyzed at FL1 (530 nm) with 170 
flow cytometer (CyFlow, Partec). 171 
 172 
2.8  Molecular modeling 173 
Computer modeling was performed as described previously [26]. The modeling of PQ 174 
or Q to TLR4 (PDB ID: 3FXI) [27, 28], SEK1 (PDB ID: 2DYL) [29], JNK1 (PDB ID: 175 
3PZE), MEK1 (PDB ID: 1S9J) [29], and ERK2 (PDB ID: 2Y9Q) was performed using 176 
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Molecular Operating Environment TM software (MOE, Version 2012.10, Chemical 177 
Computing Group Inc.). Hydrogen atoms were first added, and force field (MMFF94x) 178 
atomic charges were assigned. Docking of PQ or Q to protein was done using 179 
MOE-ASEDock 2013 software [30]. 180 
 181 
2.9  Ex vivo pull-down assay 182 
Ex vivo pull-down assay was performed as described in our previous paper [26].  183 
Briefly, PQ and Q (5 µM) were coupled to CNBr-activated Sepharose 4B beads (25 mg) 184 
in a coupling buffer [0.5 M NaCl, 0.1 M NaHCO3 (pH 8.3) and 25 % DMSO] for 185 
overnight at 4 °C according to the manufacturer’s instructions. The mixture was washed 186 
with 5 volumes of coupling buffer and then resuspended by 5 volumes of 0.1 M 187 
Tris-HCl buffer (pH 8.0) for 2 h rotation at room temperature (RT) to block any 188 
remaining active groups. After washing three cycles with acetate buffer [0.1 M acetic 189 
acid (pH 4.0) and 0.5 M NaCl], the conjugated beads were further washed by wash 190 
buffer [0.1 M Tris-HCl (pH 8.0) and 0.5 M NaCl]. The RAW264.7 cell lysates (500 191 
µg/ml) were then incubated overnight at 4 °C with Sepharose 4B beads, PQ- or 192 
Q-conjugated Sepharose 4B beads (100 µl, 50% slurry) in a reaction buffer [50 mM 193 
Tris-HCl (pH 8.5), 5 mM EDTA, 150 mM NaCl, 1mM DTT, 0.01% Nonidet P-40, 2 194 
µg/ml BSA, 0.02 mM PMSF and 1 µg protease inhibitor cocktail]. The beads were 195 
washed 5 times with 50 mM Tris-HCl (pH 7.5) containing 5 mM EDTA, 200 mM NaCl, 196 
1 mM DTT, 0.02% Nonidet P-40 and 0.02 mM PMSF. The proteins bound to the beads 197 
were detected by Western blotting with each specific antibody. 198 
 199 
2.10  Statistical analysis 200 
The difference between treated and control cells were analyzed by analysis of variance 201 
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tests or Tukey’s test. A probability of p < 0.05 was considered significant. 202 
 203 
3  Results 204 
3.1  The inhibitory effects of PQ and Q on the production of inflammatory factors 205 
To investigate the effect of PQ and Q on the production of inflammatory factors, we 206 
first used LPS-activated RAW264.7 cells [14]. As shown in Fig. 2A and 2B, the 207 
productions of LPS-induced iNOS and COX-2 protein were significantly suppressed by 208 
PQ and Q in dose-dependent manner. PQ almost completely suppressed the productions 209 
at 15 µΜ while Q slightly did even at 30 µΜ. PQ had two-fold stronger inhibition than 210 
Q.  Since iNOS and COX-2 are the enzymes to synthesize NO and PGE2, respectively, 211 
we next examined the effects of PQ and Q on the productions of NO and PGE2 in such 212 
treatment. A parallel inhibitory effects by PQ and Q were observed in LPS-induced 213 
nitrite (Fig. 2C and 2D) and PGE2 (Fig. 2E and 2F) production. These results indicated 214 
that the effective dose for the inhibition is 15 µΜ for PQ or 30 µΜ for Q, thus, we used 215 
15 µΜ PQ and 30 µΜ Q for the following cell experiments. 216 
We further examined the levels of 23 kinds of cytokines in the culture medium of 217 
treated cells as described in Section2. LPS treatment for 12 h enhanced more than 218 
five-fold level of G-CSF, TNF-α, RANTES, IL-6, MCP-1, GM-CSF, more than 219 
two-fold level of IL-12 (p70), KC, MIP-1β, IL-1α, IL-10, IL-9; and less than two-fold 220 
in IL-13, IL-1β, IL-4, IL-17, IL-3, IFN-γ, IL-12 (p40), Eotaxin, IL-5, MIP-1α, IL-2, 221 
compared to that of the cells without LPS treatment [24]. Pretreatment with PQ or Q at 222 
the indicated concentrations decreased significantly the level of IL-1α, IL-6, IFN-γ, 223 
TNF-α, IL-3, IL-9, IL-13, GM-CSF, Eotaxin, IL-17, G-CSF, and MCP-1 (Fig. 3), but 224 
did not affect significantly other 11 kinds of cytokines (data not shown). PQ also had 225 
stronger inhibition for these pro-inflammatory cytokines than Q.  226 
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 227 
3.2  Inhibition of LPS-induced paw edema in mice 228 
To confirm the anti-inflammatory effects of PQ and Q in vivo, we used the model of 229 
mouse paw edema induced by LPS (Fig. 4A) as described previously [24]. The results 230 
showed that LPS treatment increased significantly the paw thickness with maximum 231 
after 1 h and following down after 2 h. Pretreatment with 1 µM/kg PQ or 2 µM/kg Q for 4 232 
days reduced significantly LPS-induced paw thickness during this period, compared 233 
with LPS treatment alone. As controls, treatment with PBS or PQ or Q only in 2 % 234 
DMSO did not show any effect on paw edema (Fig. 4B). Simultaneously, we checked 235 
the serum level of pro-inflammatory IL-6 by ELISA. As shown in Fig. 4C, pretreatment 236 
with 1 µM/kg PQ or 2 µM/kg Q decreased significantly the level of LPS-induced IL-6. 237 
These data confirmed the anti-inflammatory effect of PQ or Q in vivo. 238 
 239 
3.3  The effect of PQ and Q on the binding of LPS to TLR4. 240 
TLR4 is a specific receptor for LPS to initiate the inflammatory responses. Our data 241 
showed that the productions of LPS-induced inflammatory mediators were suppressed 242 
by PQ and Q in both cell and mouse models. We wonder whether PQ or Q binds to 243 
TLR4 competitively with LPS to block LPS-induced inflammation. Therefore, we first 244 
performed computational analysis based on the structure of TLR4-MD2 complex (PDB 245 
ID: 3FXI) and PQ or Q. As shown in Fig. 5A, both PQ and Q docked in the most same 246 
region of TLR4-MD2 complex with three hydrogen bonds for PQ, and with four 247 
hydrogen bonds for Q. The PQ or Q binding region is different with LPS binding region, 248 
suggesting that PQ and Q may have no competition binding to TLR4-MD2 complex 249 
with LPS. To confirm this, we further used FITC-conjugated LPS to investigate whether 250 
PQ or Q binds to TLR4 competitively with LPS by flow cytometric assay (see Section 251 
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2). As shown left panel in Fig. 5B, treatment with FITC-conjugated LPS produced a 252 
strongest peak of fluorescence that could be suppressed by adding 10-fold of cold-LPS, 253 
suggesting the FITC-conjugated LPS worked in this cell system. Next, we added PQ or 254 
Q in this assay system. As shown right panel in Fig. 5B, PQ addition did not reduce the 255 
fluorescent strength. These data further support that PQ and Q may have no competitive 256 
binding to TLR4-MD2 complex with LPS although PQ or Q itself shows fluorescence 257 
in this wavelength. Thus, these data suggest that PQ or Q might exert anti-inflammatory 258 
action by targeting cytoplasmic protein kinases. 259 
 260 
3.4  Modulation of PQ and Q on MAPK signaling 261 
Our data revealed that the inhibition of PQ or Q on inflammatory factors is not due to its 262 
competitive binding to TLR4. It is recently noticed that PQ or Q can efflux the cells [31, 263 
32] and modulate MAPK signaling to regulate pro-inflammatory mediators. Thus, we 264 
investigated the effects of PQ and Q on the LPS-induced phosphorylation of MAPK in 265 
RAW264.7 cells. The cells were treated with 15 µΜ PQ or 30 µΜ Q for 30 min before 266 
exposure to 40 ng/ml LPS for 30 min. As shown in Fig. 6, PQ suppressed markedly 267 
phosphorylation of SEK1-JNK1/2 and MEK1-ERK1/2 signaling while Q only slightly 268 
suppressed them. Both PQ and Q did not suppress the phosphorylation of MKK3/6-p38 269 
(data not shown).  270 
 271 
3.5  Binding ability of PQ and Q to SEK1-JNK1/2 and MEK1-ERK1/2  272 
Our data suggest that SEK1-JNK1/2 and MEK1-ERK1/2 are potential targets for PQ 273 
and Q to inhibit inflammatory signaling. Thus, we investigated whether the PQ and Q 274 
bind to each protein kinase directly, using bead-bound pulldown assay which has been 275 
validated as effective screening tool in our previous study [26]. PQ or Q is coupled with 276 
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CNBr-sepharose 4B beads, and then incubated with protein lysate extracted from 277 
RAW264.7 cells. Bound protein kinase was detected by Western blotting with antibody 278 
after washing out. As shown in Fig. 7A, SEK1 and JNK1/2 were detected in the 279 
Sepharose 4B beads coupled with PQ (54.2% and 31.6% binding rate) and with Q 280 
(31.6% and 12.6% binding rate), but was not detected in the Sepharose 4B beads alone. 281 
As the same fashion, MEK1 and ERK1/2 were detected in the Sepharose 4B beads 282 
coupled with PQ (75.6% and 77.3% binding rate), and with Q (21.2% and 37.1 % 283 
binding rate), but was not detected in the Sepharose 4B beads alone (As shown in Fig. 284 
7B). These data showed that PQ and Q could bind directly to SEK1, JNK1/2, MEK1 285 
and ERK1/2. Moreover, PQ had stronger binding activity to these protein kinases than 286 
Q.  287 
 288 
3.6  Docking model between PQ/Q and SEK1-MEK1 kinases 289 
To know how PQ or Q binds to SEK1 and MEK1 kinases, we performed computer 290 
modeling of PQ or Q bound to these protein kinases, using the software as described in 291 
Section 2. The results provided the interesting information that three hydrogen bonds 292 
were formed between PQ and Glu175 and Asp259 residues of MKK4 (SEK1), which 293 
configured nearby ATP-binding pocket in left panel, and four hydrogen bonds were 294 
formed between Q and Glu175, Asp259, and Asp277 residues of MKK4 (SEK1), which 295 
configured a part of ATP-binding pocket in right panel. The domains for PQ and Q 296 
binding are very close, almost the same. As shown in Fig. 8B, two hydrogen bonds were 297 
formed between PQ and Lys55 and Asp151 residues of JNK1, which configured a part 298 
of ATP-binding pocket in right panel, and three hydrogen bonds were formed between 299 
Q and Val80, Glu109, and Lys166 residues of JNK1, which configured a part of 300 
ATP-binding pocket in left panel. The domains for PQ and Q binding are in different 301 
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domains. Three hydrogen bonds were formed between PQ and Arg181, Glu182 and 302 
Asp351 residues of MEK1 (Fig.8C), which configured a part of MEK1 catalytic domain 303 
in right panel. Two hydrogen bonds were formed between Q and Asp365 of MEK1, 304 
which configured a part of MEK1 catalytic domain in left panel. The domains of MEK1 305 
for PQ and Q binding are different (Fig.8C). Four hydrogen bonds were formed 306 
between PQ and Asp251, Lys272 and Asp291 residues of ERK2 (Fig. 8D), which 307 
configured a part of ERK2 catalytic domain in left panel, and four hydrogen bonds were 308 
formed between Q and MEK1, same as PQ in left panel. These docking results support 309 
our pull-down binding data between PQ or Q and SEK1-MEK1 kinases. 310 
 311 
4  Discussion 312 
In the present study, we investigated the anti-inflammatory effects and molecular 313 
mechanisms of 8-prenyl quercetin, compared to its parent quercetin, in both cell and 314 
animal models. In the cell model, we demonstrated that PQ had more than two-fold 315 
stronger inhibition on LPS-induced productions of pro-inflammatory factors (iNOS, NO, 316 
COX-2, PGE2) and cytokines (IL-1α, IL-6, IFN-γ, TNF-α, IL-3, IL-9, IL-13, GM-CSF, 317 
Eotaxin, IL-17, G-CSF, and MCP-1, IL-12 (p70), TNF-α, and MCP-1). In the animal 318 
model, we observed that PQ also showed more than two-fold stronger inhibition on 319 
mouse paw edema (Fig. 4). Thus, our data suggested that PQ is more potential inhibitor 320 
for LPS-induced inflammation than its parent form. 321 
The issues concerned are the molecular mechanisms that how PQ suppressed 322 
LPS-induced inflammation. TLR4 is an important sensor for LPS by enhancing the 323 
binding of LPS to MD-2 to form LPS-TLR4-MD2 complex to trigger signaling 324 
cascades that involve activation of MAPK, NF-κB, and anti-inflammatory mediators 325 
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[33]. We wonder whether PQ and Q compete with LPS for binding to TLR4. To clarify 326 
this, we first performed computational docking analysis based on the structure of 327 
TLR4-MD2 complex (PDB ID: 3FXI) and PQ or Q. The data showed that both PQ and 328 
Q docked in the different domain of TLR4-MD2 complex with LPS, suggesting that PQ 329 
and Q might have no competitive binding to TLR4-MD2 complex with LPS. To confirm 330 
this, we further used FITC-conjugated LPS to investigate whether PQ or Q has 331 
competitive binding with TLR4 by flow cytometric assay. Our data showed that both 332 
PQ and Q did not reduce the fluorescent strength by FITC-conjugated LPS, further 333 
supporting that PQ and Q might have no competitive binding to TLR4-MD2 complex 334 
with LPS. These data suggest that PQ and Q might attenuate cellular inflammatory 335 
signaling by inhibiting the activation of cellular protein kinases. 336 
MAPK signaling is one of the important cell signaling pathways that regulate 337 
cytokines and pro-inflammatory mediators such as IL-1, IL-6, TNF-α, and iNOS during 338 
inflammatory response although the cellular signaling pathways regulating 339 
inflammation are very complicated. We first investigated the potential of PQ and Q 340 
binding to MAP kinases by the bead-bound pulldown assay, which has been validated 341 
as an effective screening tool in our previous study [26]. SEK1-JNK1/2 and 342 
MEK1-ERK1/2 were detected in the Sepharose 4B beads coupled with PQ and cellular 343 
lysate, but not found in Sepharose 4B beads alone (Fig. 7). These data supported that 344 
PQ might target the signaling molecules of SEK1-JNK1/2 and MEK1-ERK1/2 by direct 345 
binding. Furthermore, we performed computer modeling of PQ and Q bound to 346 
SEK1-JNK1/2 and MEK1-ERK1/2, using the software of three dimensional 347 
pharmacophore modeling for the interaction of a small molecule with protein. The 348 
results provided the interesting information that several hydrogen bonds were found 349 
between the hydroxyl groups of PQ or Q and amino acid residues of SEK1-JNK1/2 and 350 
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MEK1-ERK1/2 (Fig. 8A- 8D). 351 
Moreover, the docking domain by PQ or Q is not completely located in the 352 
ATP-binding pocket of these protein kinases, but configured nearby or a part of 353 
ATP-binding pocket. These data at least suggest that PQ or Q may dock these domains 354 
to modulate the 3D-structure of these protein kinases to influence the phosphorylation, 355 
rather than competing with ATP. Our data indicate that the downregulation of 356 
SEK1-JNK1/2 and MEK1-ERK1/2 pathways by PQ or Q is at least involved in the 357 
inhibition of LPS-induced inflammation. 358 
On the other hand, direct binding efficiency for PQ is 2-3 fold higher than that for Q 359 
although the binding domains of these protein kinases for PQ and Q were very close, 360 
almost the same. The reason may be related to the efficiency of cellular uptake and 361 
bioaccumulation. It is reported that prenylation increased the hydrophobicity and 362 
affinity of Q to hydrophobic phospholipid bilayer membranes [31], which might 363 
enhance the cellular uptake of flavonoids and result in their biological activities in in 364 
vitro model systems [3]. In vivo data confirmed that prenylation enhances accumulation 365 
of naringenin in mouse muscle tissue after long-term feeding, and accumulation of 366 
quercetin in liver tissue [5]. Therefore, our data could support that the higher direct 367 
binding efficiency for PQ may be due to its efficiency in cellular uptake and 368 
bioaccumulation enhanced by prenylation. 369 
 In summary, we demonstrated that 8-prenyl quercetin has stronger anti-inflammatory 370 
activity than its parent form in vitro and in vivo. Moreover, the downregulation of 371 
MAPK signaling pathways is at least involved in the inhibition of inflammatory 372 
mediators by PQ. Direct binding assay and molecule docking analysis revealed that 373 
SEK1-JNK1/2 and MEK1-ERK1/2 might be direct molecule targets for PQ. These 374 
results from cell and mouse models provide a comprehensive data for understanding the 375 
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anti-inflammatory effects and molecular mechanisms of PQ. 376 
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Figure Legends: 476 
 477 
Figure 1. The chemical structures of 8-prenyl quercetin (PQ) and quercetin (Q) 478 
 479 
Figure 2. Influence of PQ and Q on the inflammatory mediators. PQ (A) and Q (B) 480 
inhibited LPS-induced expression of iNOS and COX-2. RAW264.7 cells were treated 481 
with the indicated concentrations of each sample for 30 min, and then exposed to 40 482 
ng/ml LPS for 12 h. COX-2 and iNOS were detected by Western blotting as described 483 
in Section 2. PQ (C, E) and Q (D, F) also inhibited the productions of LPS-induced NO 484 
and PGE2. RAW264.7 cells were treated as the same as above. The amount of nitrite (C, 485 
D) and PGE2 (E, F) in culture medium were measured as described in Section 2. Each 486 
value represents the mean ±S.D. of triplicate cultures. Means with differently lettered 487 
superscripts differ significantly each other at the probability of p < 0.05. 488 
 489 
Figure 3. Influence of PQ and Q on the productions of LPS-induced cytokines. The 490 
culture and treatment of RAW264.7 cells were performed as described in Figure 2. The 491 
amounts of cytokines in culture medium were measured by the multi-plex technology as 492 
described in Section 2. Each value represents the mean ± S.D. of triplicate cultures. 493 
Means with asterisk superscripts differ significantly at the probability of p < 0.05. 494 
 495 
Figure 4. Inhibition of PQ and Q on LPS-induced mouse paw edema. The mice were 496 
divided into four groups: control, LPS, LPS plus PQ or Q, PQ or Q only. Each group 497 
had three mice, respectively. PQ (1 μM/kg) or Q (2 μM/kg) was injected i.p. for 4 days, 498 
and LPS (1 mg/kg) was then injected s.c. at mouse paw. The paw thickness was 499 
measured using digital caliper before and every hour after LPS treatment until 3 h (A). 500 
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The change in paw edema thickness was shown in (B). Means with differently lettered 501 
superscripts differ significantly against control at the probability of p < 0.05. The 502 
change in level of serum IL-6 is shown in (C). The blood serums were obtained from 503 
the mice that were treated with or without LPS for 3 h by collection of heart blood. The 504 
serum IL-6 was measured as described in Section 2. Each value represents the mean ± 505 
S.D. of three mice. Means with asterisk superscripts differ significantly at the 506 
probability of p < 0.05. 507 
 508 
Figure 5. (A) The models of PQ and Q docking to TLR4. Hydrogen bonds are indicated 509 
by green lines in lower figure. Blue ribbon: TLR4 (Chain A), green ribbon: MD2 510 
(Chain B), orange: PQ, yellow: Q, red: LPS (Color figure online). (B) The competitive 511 
binding assay for PQ to TLR4 with FITC-conjugated LPS. RAW264.7 cells (5×105 512 
cells/ml in serum-free medium) were treated with or without PQ (15 μM) or cold-LPS 513 
(unlabeled-LPS) (100 ng/ml) for 30 min before exposure to FITC-LPS (10 ng/ml) for 30 514 
min. After washing, the fluorescence emitted was analyzed with flow cytometry as 515 
described in Section 2. 516 
 517 
Figure 6. Suppression of PQ and Q on the phosphorylation of SEK1, JNK1/2, MEK1 518 
and ERK1/2. RAW264.7 cells were pretreated with the indicated concentrations of PQ 519 
or Q for 30 min, and then exposed to 40 ng/ml LPS for 30 min. The phosphorylated 520 
protein kinases and α-tubulin were detected with their antibodies, respectively. The 521 
induction fold of the phosphorylated kinase was calculated as the intensity of the 522 
treatment relative to that of control normalized to α-tubulin by densitometry. The blots 523 
shown are the examples of three separate experiments. 524 
 525 
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Figure 7. Binding abilities of PQ and Q to SEK1 and JNK1/2 (A), MEK1 and ERK1/2 526 
(B). Whole cell lysate (input control, lane 1), lysate precipitation with Sepharose 4B 527 
beads (negative control, lane 2), Sepharose 4B-PQ-coupled beads (lane 3), and 528 
Sepharose 4B-Q-coupled beads (lane 4) were applied to SDS-PAGE and then detected 529 
with SEK1, JNK1/2, MEK1 or ERK1/2 antibody, respectively. The binding efficiency 530 
of each protein kinase to PQ or Q was presented as the ratio of input control, 531 
respectively. 532 
 533 
Figure 8. The models of PQ and Q docking to MKK4 (SEK1) (A), JNK1 (B), MEK1 534 
(C), and ERK2 (D). Electrostatic potential surface is indicated in close-up figure of 535 
upper side, and hydrogen bonds are indicated by blue and green lines in lower figure. 536 
Blue ribbon: protein kinase, red ribbon: ATP-binding site, orange: PQ, yellow: Q (Color 537 
figure online). 538 











